Steven Harr is President, Chief Executive Officer, and Director of Sana Biotechnology, Inc. (SANA). The company reported total compensation of $2,903,010 for fiscal year 2025.
| Salary | $696,140 |
|---|---|
| Bonus | $0 |
| Stock awards | $425,001 |
| Option awards | $1,327,500 |
| Non-equity incentive plan | $450,369 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $4,000 |
| Total | $2,903,010 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Sana Biotechnology, Inc. filed April 24, 2026, accession 0001193125-26-174883.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Steven Harr this page | President, Chief Executive Officer, and Director | $2,903,010 |
| Bernard Cassidy | Former Executive Vice President, General Counsel, and Corporate Secretary | $1,016,113 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Sana Biotechnology, Inc. compensation brief.
Steven Harr's compensation sits inside Sana Biotechnology, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.